UBS Group’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52K | Buy |
+2,154
| New | +$2.52K | ﹤0.01% | 8123 |
|
|
2025
Q1 | – | Sell |
-194
| Closed | -$237 | – | 8859 |
|
|
2024
Q4 | $237 | Buy |
+194
| New | +$237 | ﹤0.01% | 8308 |
|
|
2024
Q3 | – | Sell |
-15,953
| Closed | -$43.1K | – | 8239 |
|
|
2024
Q2 | $43.1K | Buy |
+15,953
| New | +$43.1K | ﹤0.01% | 5666 |
|
|
2023
Q3 | – | Sell |
-1,223
| Closed | -$4.16K | – | 8262 |
|
|
2023
Q2 | $4.16K | Buy |
+1,223
| New | +$4.16K | ﹤0.01% | 6480 |
|
|
2022
Q4 | – | Sell |
-30
| Closed | – | – | 9480 |
|
|
2022
Q3 | $0 | Sell |
30
-132
| -81% | – | ﹤0.01% | 9168 |
|
|
2022
Q2 | $3K | Buy |
+162
| New | +$3K | ﹤0.01% | 8228 |
|
|
2021
Q4 | – | Sell |
-59
| Closed | -$2K | – | 9087 |
|
|
2021
Q3 | $2K | Buy |
+59
| New | +$2K | ﹤0.01% | 7770 |
|
|
2021
Q1 | – | Sell |
-70
| Closed | -$3K | – | 7888 |
|
|
2020
Q4 | $3K | Buy |
+70
| New | +$3K | ﹤0.01% | 6947 |
|
|
2020
Q3 | – | Sell |
-25
| Closed | -$1K | – | 7050 |
|
|
2020
Q2 | $1K | Sell |
25
-256
| -91% | -$10.2K | ﹤0.01% | 6872 |
|
|
2020
Q1 | $8K | Buy |
+281
| New | +$8K | ﹤0.01% | 6146 |
|
|
2019
Q4 | – | Sell |
-124
| Closed | -$4K | – | 6997 |
|
|
2019
Q3 | $4K | Buy |
+124
| New | +$4K | ﹤0.01% | 6559 |
|
|
2019
Q2 | – | Sell |
-62
| Closed | -$4K | – | 6945 |
|
|
2019
Q1 | $4K | Sell |
62
-528
| -89% | -$34.1K | ﹤0.01% | 6405 |
|
|
2018
Q4 | $19K | Buy |
+590
| New | +$19K | ﹤0.01% | 5896 |
|
|
2018
Q3 | – | Sell |
-141
| Closed | -$5K | – | 7012 |
|
|
2018
Q2 | $5K | Buy |
+141
| New | +$5K | ﹤0.01% | 6526 |
|
|
2018
Q1 | – | Sell |
-5
| Closed | – | – | 6864 |
|
|
2017
Q4 | $0 | Sell |
5
-104
| -95% | – | ﹤0.01% | 6831 |
|
|
2017
Q3 | $13K | Sell |
109
-28
| -20% | -$3.34K | ﹤0.01% | 5817 |
|
|
2017
Q2 | $13K | Sell |
137
-90
| -40% | -$8.54K | ﹤0.01% | 5648 |
|
|
2017
Q1 | $50K | Sell |
227
-858
| -79% | -$189K | ﹤0.01% | 4627 |
|
|
2016
Q4 | $152K | Sell |
1,085
-26
| -2% | -$3.64K | ﹤0.01% | 4111 |
|
|
2016
Q3 | $189K | Sell |
1,111
-168
| -13% | -$28.6K | ﹤0.01% | 3767 |
|
|
2016
Q2 | $345K | Buy |
1,279
+1,191
| +1,353% | +$321K | ﹤0.01% | 3407 |
|
|
2016
Q1 | $18K | Buy |
88
+52
| +144% | +$10.6K | ﹤0.01% | 5443 |
|
|
2015
Q4 | $10K | Sell |
36
-7
| -16% | -$1.94K | ﹤0.01% | 5983 |
|
|
2015
Q3 | $21K | Buy |
43
+26
| +153% | +$12.7K | ﹤0.01% | 5387 |
|
|
2015
Q2 | $2K | Buy |
17
+10
| +143% | +$1.18K | ﹤0.01% | 6523 |
|
|
2015
Q1 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 6513 |
|